We are developing two assays to support the COVID-19 diagnostic effort. AgPlus has been working on an antigen assay and antibody assay.
Key Partner STI supports Ground-breaking Antibiotic Resistance Project
White Paper : The impact of implementing the new In Vitro Diagnostic Regulations on SMEs
Ag Plus release new white paper – This piece of work has shown that dual detection system for two different analytes can be accomplished on the AgPlus system using differing AuNP and AgNP simultaneously.
We discuss the problems of developing a near patient diagnostic assay…
Every 4 minutes worldwide someone dies from infection caused by bacteria that are resistant to antibiotics. Using a Point of Care Assay to detect Human Neutrophil Lipocalin would improve patient outcome.
Point-of-care tests (POCT) offer rapid diagnostic and/or predictive results in real-time thereby facilitating clinical decision making. We discuss how our technology overcomes implementation challenges.